Compound E, chemically designated as 209986-17-4 (CAS), represents a significant study within the field of Alzheimer's illness research. This γ-secretase modulator was initially developed as a promising therapeutic https://laytnujbe353737.activoblog.com/51187788/γ-secretase-blocker-compound-e-209986-17-4